Horizon Space Acquisition I Corp.
corporate_fare Company Profile
Horizon Space Acquisition I Corp. (OTC:HSPOF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for HSPOF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-13, rated 8/10. Across its 3 most recent items scored 7 or higher, the top rating is 8/10, with 2 rated 8 or above.
Recent high-impact activity:
- SPAC Horizon Space to Merge with ArcheNova Biotech, Listing on Nasdaq
- Horizon Space Acquisition I Reports $0.204M Net Income, Trust Income Plunges to $0.780M in 2025 10-K
- Horizon Space Acquisition I Boosts Estimated Redemption Price to $12.725 Per Share
Short Interest & Short Volume
5.83 days to coverFINRA reported short interest of 210 shares in HSPOF as of the October 30, 2026 settlement, unchanged from the prior period — about 5.8 days to cover at its recent average daily volume. On November 20, 2026, 100.0% of HSPOF volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.